Theriva Biologics, Inc. Quarterly Return On Assets in % from Q1 2012 to Q4 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Theriva Biologics, Inc. annual/quarterly Return On Assets history and growth rate from Q1 2012 to Q4 2022.
  • Theriva Biologics, Inc. Return On Assets for the quarter ending December 31, 2022 was -24.7 %, a 30.7% decline year-over-year.
  • Theriva Biologics, Inc. annual Return On Assets for 2023 was -29.4 %, a 18.7% decline from 2022.
  • Theriva Biologics, Inc. annual Return On Assets for 2022 was -24.7 %, a 30.7% decline from 2021.
  • Theriva Biologics, Inc. annual Return On Assets for 2021 was -18.9 %, a 82.5% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -24.7 -5.8 -30.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -23.3 -4.8 -25.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -21.9 +1.19 +5.14% Apr 1, 2022 Jun 30, 2022
Q1 2022 -20.5 +16.4 +44.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -18.9 +89.4 +82.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -18.5 +78 +80.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -23.1 +71.7 +75.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -36.9 +43 +53.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -108 -39.3 -56.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -96.5 -36 -59.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -94.8 -34 -56% Apr 1, 2020 Jun 30, 2020
Q1 2020 -79.9 -3.14 -4.09% Jan 1, 2020 Mar 31, 2020
Q4 2019 -69.1 +17.5 +20.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -60.5 -2.06 -3.52% Jul 1, 2019 Sep 30, 2019
Q2 2019 -60.8 +32.1 +34.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -76.8 +7.13 +8.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -86.6 -4.63 -5.65% Oct 1, 2018 Dec 31, 2018
Q3 2018 -58.5 +46.4 +44.3% Jul 1, 2018 Sep 30, 2018
Q2 2018 -92.9 +21.3 +18.7% Apr 1, 2018 Jun 30, 2018
Q1 2018 -83.9 +38.2 +31.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -82 +77.3 +48.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -105 +82.6 +44% Jul 1, 2017 Sep 30, 2017
Q2 2017 -114 +12.5 +9.84% Apr 1, 2017 Jun 30, 2017
Q1 2017 -122 +38.9 +24.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -159 +21.6 +11.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -187 -4.36 -2.38% Jul 1, 2016 Sep 30, 2016
Q2 2016 -127 +176 +58.1% Apr 1, 2016 Jun 30, 2016
Q1 2016 -161 +80.4 +33.3% Jan 1, 2016 Mar 31, 2016
Q4 2015 -181 -7.75 -4.48% Oct 1, 2015 Dec 31, 2015
Q3 2015 -183 -19.3 -11.8% Jul 1, 2015 Sep 30, 2015
Q2 2015 -302 -160 -113% Apr 1, 2015 Jun 30, 2015
Q1 2015 -241 -119 -96.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -173 -62.5 -56.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -164 +29.7 +15.3% Jul 1, 2014 Sep 30, 2014
Q2 2014 -142 +42.6 +23.1% Apr 1, 2014 Jun 30, 2014
Q1 2014 -123 +66.8 +35.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 -111 +85.3 +43.5% Oct 1, 2013 Dec 31, 2013
Q3 2013 -193 -80.1 -70.7% Jul 1, 2013 Sep 30, 2013
Q2 2013 -185 -92 -99.2% Apr 1, 2013 Jun 30, 2013
Q1 2013 -190 -105 -125% Jan 1, 2013 Mar 31, 2013
Q4 2012 -196 Oct 1, 2012 Dec 31, 2012
Q3 2012 -113 Jul 1, 2012 Sep 30, 2012
Q2 2012 -92.7 Apr 1, 2012 Jun 30, 2012
Q1 2012 -84.2 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.